Aculys_log

Aculys Pharma Initiates Phase 3 Trial of Pitolisant Treating Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea Syndrome

MINATO-KU, TOKYO, Japan--(BUSINESS WIRE)--Aculys Pharma, Inc. (“Aculys”), a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions,...

logo-136

Asia Pacific E-Learning Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Delivery Mode, Learning Mode, and End User – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific E-Learning Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Delivery Mode, Learning Mode,...